Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06951880
PHASE1

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.

Official title: A Phase I, Randomized, Single-blind, Placebo-controlled, 2-Part Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD4916 Following Single- and Multiple-ascending-dose Administration to Healthy Adult Volunteers (Including Japanese and Chinese Healthy Volunteers)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

178

Start Date

2025-06-27

Completion Date

2026-09-24

Last Updated

2025-04-30

Healthy Volunteers

Yes

Interventions

DRUG

AZD4916

AZD4916 will be administered as oral solution.

OTHER

Placebo

Placebo will be administered as oral solution.

Locations (1)

Research Site

Harrow, United Kingdom